Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Amendments topic

No spam. Unsubscribe anytime.

FDA recommends tabular 'summary of changes' in DMF amendments

Office of Pharmaceutical Quality (presenter) · July 30, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Agency official advised that DMF amendment submissions include a clear summary-of-changes table (section, current parameter, proposed change, justification) plus supporting data to help assessors focus on updates and risks.

The presenter urged DMF holders to include a concise, tabular summary of changes when submitting amendments, listing the affected section, current parameters, the change proposed, and a justification. She noted that longer justifications and supporting data can be attached but that the summary table helps assessors zero in on what has changed.

The Agency official added that a clear justification—ideally with data and a discussion of process or quality risk—helps reviewers evaluate the impact of the amendment and reduces unnecessary follow-up requests.